🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
The aim of the study is to test \[90\]Y-ibritumomab tiuxetan, a radioactive...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00185393
Treatments Being Tested
The purpose of this study is to determine the complete response rate when C...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2003-11
Trial ID
NCT00177554
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Unknown
Location
Medizinische Klinik, Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00397800
Treatments Being Tested
This phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxeta...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2015-02-11
Trial ID
NCT02320292
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-11
Trial ID
NCT00005592
Treatments Being Tested
The purpose of this study is to see how well Zevalin works in the treatment...
Status
Withdrawn
Location
Cross Cancer Institute
Start Date
TBD
Trial ID
NCT00414089
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2003-02-10
Trial ID
NCT00058422
This study is a regulatory post marketing surveillance in Japan, and it is ...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT01448928
Treatments Being Tested